![John Brock-Utne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Brock-Utne
Corporate Officer/Principal at Stanford University Hospital
John Brock-Utne active positions
Companies | Position | Start | End |
---|---|---|---|
Stanford University Hospital
![]() Stanford University Hospital Hospital/Nursing ManagementHealth Services Stanford University Hospital operates as a hospital. The private company is based in Palo Alto, CA. | Corporate Officer/Principal | 2010-05-13 | - |
Career history of John Brock-Utne
Former positions of John Brock-Utne
Companies | Position | Start | End |
---|---|---|---|
Spectros Corp.
![]() Spectros Corp. Medical SpecialtiesHealth Technology Spectros Corp. develops, markets, and licenses medical devices based on in vivo molecular optical technologies, including clinical devices for detection of ischemia and cancer. Its medical devices utilize optical technologies that speed diagnosis, enable real-time therapies and reduce complications. The company's flagship product, the T-Stat Tissue Oximeter, is a medical device that is sensitive to ischemia, an insufficient supply of oxygen to tissue. The firm is also developing molecular imaging contrast agents for surgical guidance during breast and prostate cancer surgeries. Spectros was incorporated on April 19, 1995 and is headquartered in Portola Valley, CA. | Director/Board Member | - | - |
Statistics
International
United States | 3 |
Operational
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Spectros Corp.
![]() Spectros Corp. Medical SpecialtiesHealth Technology Spectros Corp. develops, markets, and licenses medical devices based on in vivo molecular optical technologies, including clinical devices for detection of ischemia and cancer. Its medical devices utilize optical technologies that speed diagnosis, enable real-time therapies and reduce complications. The company's flagship product, the T-Stat Tissue Oximeter, is a medical device that is sensitive to ischemia, an insufficient supply of oxygen to tissue. The firm is also developing molecular imaging contrast agents for surgical guidance during breast and prostate cancer surgeries. Spectros was incorporated on April 19, 1995 and is headquartered in Portola Valley, CA. | Health Technology |
Stanford University Hospital
![]() Stanford University Hospital Hospital/Nursing ManagementHealth Services Stanford University Hospital operates as a hospital. The private company is based in Palo Alto, CA. | Health Services |
- Stock Market
- Insiders
- John Brock-Utne
- Experience